EditorialNephrogenic Fibrosing Dermopathy/Nephrogenic Systemic Fibrosis—Setting the Record Straight
References (19)
- et al.
Scleromyxoedema-like cutaneous disease in renal-dialysis patients
Lancet
(2000) - et al.
Nephrogenic fibrosing dermopathy (scleromyxedema-like illness of renal disease)
J Am Acad Dermatol
(2003) - et al.
Nephrogenic fibrosing dermopathya novel cutaneous fibrosing disorder in patients with renal failure
Am J Med
(2003) - et al.
Circulating fibrocytescollagen-secreting cells of the peripheral blood
Int J Biochem Cell Biol
(2004) - et al.
Description of twelve cases of nephrogenic fibrosing dermopathy and review of the literature
Semin Arthritis Rheum
(2005) - et al.
Nephrogenic fibrosing dermopathy
Am J Dermatopathol
(2001) - et al.
Dialysis-associated systemic fibrosis (nephrogenic fibrosing dermopathy)
Arthritis Rheum
(2004) - et al.
Involvement of skeletal muscle in dialysis-associated fibrosis (nephrogenic fibrosing dermopathy)
Muscle Nerve
(2004) Nephrogenic fibrosing dermopathythe first 6 years
Curr Opin Rheumatol
(2003)
Cited by (80)
Gadolinium Retention and Toxicity—An Update
2017, Advances in Chronic Kidney DiseaseGadolinium deposition disease: Initial description of a disease that has been around for a while
2016, Magnetic Resonance ImagingCitation Excerpt :Based on these results, we propose a name for this presumed disease process in subjects with normal renal function and gadolinium toxicity, Gadolinium Deposition Disease (GDD). At least 60% of our subjects showed a glove-and-sock distribution of disease associated with intense sharp “pins and needles” or burning pain, and skin changes, resembling NSF [11–13]. Other examples of similar but less severe changes compared to NSF include: tissue in NSF is often described as woody and joint contractions severe, whereas subjects in our survey have reported as spongy or rubbery, and joint flexures minimal.
The kidney and rheumatic disease
2015, Rheumatology: Sixth EditionAdverse events caused by MRI contrast agents: Implications for radiographers who inject
2012, RadiographyCitation Excerpt :In addition the RCR26 states that the appropriate use of questionnaire screening including history of renal disease, prior kidney surgery, hypertension, gout, diabetes mellitus may be adequate and if there are any positive responses then serum creatinine levels should be obtained. With extended roles for MRI radiographers, practice is rapidly expanding especially in the areas of prescribing and administration of contrast agents whilst there are now several MRI radiographers undertaking image interpretation.20 Radiographers are well placed in contributing to the establishment of departmental policies for the safe use and administration of contrast agents as per the Patient Group Directives.38
Nephrogenic Systemic Fibrosis and Gadolinium-Based Contrast Agents
2011, Advances in Chronic Kidney DiseaseCitation Excerpt :The association of NSF with one particular factor remained elusive. Information from the NSF registry before 2006 led to the suspicion that a contrast agent was an important common factor among affected patients, although confirmation of this suspicion was complicated by incomplete and unavailable medical records.23 It was the report by Grobner from Austria that ignited the field on making the remarkable association of NSF with an antecedent exposure to a GBCA formulation containing gadodiamide (Omniscan, GE Healthcare Inc., Princeton, NJ) in 5 of 9 patients with ESRD who received triple doses for magnetic resonance (MR) angiograms.24
The use of gadolinium for arterial interventions
2011, Annals of Vascular SurgeryCitation Excerpt :Other clinical manifestations include pain, swelling, hyperpigmentation, erythema, pruritis, and muscle weakness. The fibrotic process is not limited to the skin and multiple studies have proven that systemic involvement is common with progression of the disease.42,43 Treatment for the disease is limited and complete resolution is very rare.